BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2026 9:36:22 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-17 10:04 |
|
Peer-Review Started |
|
2026-03-17 10:04 |
|
First Decision by Editorial Office Director |
|
2026-04-02 05:43 |
|
Return for Revision |
|
2026-04-02 05:43 |
|
Revised |
|
2026-04-10 09:06 |
|
Publication Fee Transferred |
|
2026-04-21 10:19 |
|
Second Decision by Editor |
|
2026-05-18 02:49 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-18 06:48 |
|
Articles in Press |
|
2026-05-18 06:48 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-27 08:36 |
|
Publish the Manuscript Online |
|
2026-07-27 09:36 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical and radiomic characteristics of transarterial chemoembolization combined with immunotherapy in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qian Xia, Wei Shan and Hao Yan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hao Yan, Associate Chief Physician, Research Fellow, Department of Interventional Vascular Surgery, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenhe District, Shenyang 110001, Liaoning Province, China. yanhaobzjr@163.com |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; Immunotherapy; Therapeutic efficacy; Radiomics; Prediction |
| Core Tip |
Transarterial chemoembolization + immunotherapy co-treatment can significantly improve short-term objective response rate and disease control rate in intermediate-advanced hepatocellular carcinoma patients and more effectively regulate relevant serum biomarkers. Radiomic features extracted from pre-treatment imaging can serve as a potential strategy for constructing personalized efficacy prediction models. |
| Publish Date |
2026-07-27 09:36 |
| Citation |
Xia Q, Shan W, Yan H. Clinical and radiomic characteristics of transarterial chemoembolization combined with immunotherapy in hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(7): 119397
|
| URL |
https://www.wjgnet.com/1948-9366/full/v18/i7/119397.htm |
| DOI |
https://doi.org/10.4240/wjgs.v18.i7.119397 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
